Zurcher Kantonalbank (Zurich Cantonalbank) Arcturus Therapeutics Holdings Inc. Transaction History

Zurcher Kantonalbank (Zurich Cantonalbank)

$34.1 Billion
Q4 2024

A detailed history of Zurcher Kantonalbank (Zurich Cantonalbank) transactions in Arcturus Therapeutics Holdings Inc. stock. As of the latest transaction made, Zurcher Kantonalbank (Zurich Cantonalbank) holds 8,599 shares of ARCT stock, worth $147,730. This represents 0.0% of its overall portfolio holdings.

Number of Shares

8,599

Previous 8,694 1.09%

Holding current value

$147,730

Previous $201,000 27.86%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 07, 2025	SELL	$14.82 - $25.48 $1,407 - $2,420	-95 Reduced 1.09%	8,599 $145,000
Q3 2024 Nov 07, 2024	BUY	$18.08 - $25.38 $15,295 - $21,471	846 Added 10.78%	8,694 $201,000
Q2 2024 Jul 29, 2024	SELL	$24.35 - $44.39 $4,480 - $8,167	-184 Reduced 2.29%	7,848 $191,000
Q1 2024 Apr 25, 2024	BUY	$31.23 - $42.99 $12,242 - $16,852	392 Added 5.13%	8,032 $271,000
Q4 2023 Jan 30, 2024	SELL	$17.71 - $32.97 $6,853 - $12,759	-387 Reduced 4.82%	7,640 $240,000
Q3 2023 Oct 25, 2023	SELL	$25.44 - $37.35 $120,941 - $177,561	-4,754 Reduced 37.2%	8,027 $205,000
Q2 2023 Aug 07, 2023	BUY	$23.94 - $32.36 $167,292 - $226,131	6,988 Added 120.63%	12,781 $366,000
Q4 2022 Feb 01, 2023	BUY	$14.14 - $23.06 $12,471 - $20,338	882 Added 17.96%	5,793 $98,000
Q3 2022 Nov 09, 2022	SELL	$13.05 - $22.13 $352 - $597	-27 Reduced 0.55%	4,911 $73,000
Q2 2022 Aug 09, 2022	SELL	$12.26 - $31.17 $3,212 - $8,166	-262 Reduced 5.04%	4,938 $78,000
Q1 2022 Apr 21, 2022	SELL	$17.64 - $39.57 $458 - $1,028	-26 Reduced 0.5%	5,200 $140,000
Q4 2021 Feb 01, 2022	BUY	$34.2 - $47.56 $34 - $47	1 Added 0.02%	5,226 $193,000
Q3 2021 Nov 15, 2021	SELL	$27.88 - $58.25 $1,449 - $3,029	-52 Reduced 0.99%	5,225 $250,000
Q2 2021 Jul 30, 2021	BUY	$25.79 - $42.11 $3,017 - $4,926	117 Added 2.27%	5,277 $179,000
Q1 2021 May 03, 2021	BUY	$38.75 - $86.92 $118,613 - $266,062	3,061 Added 145.83%	5,160 $213,000
Q4 2020 Jan 28, 2021	BUY	$34.61 - $123.66 $13,047 - $46,619	377 Added 21.89%	2,099 $91,000
Q3 2020 Nov 06, 2020	BUY	$37.49 - $63.19 $35,090 - $59,145	936 Added 119.08%	1,722 $74,000
Q2 2020 Jul 28, 2020	BUY	$12.66 - $58.27 $9,950 - $45,800	786 New	786 $37,000

Others Institutions Holding ARCT

# of Institutions

174

Shares Held

25.3M

Call Options Held

195K

Put Options Held

133K

View Full List

About Arcturus Therapeutics Holdings Inc.

Ticker ARCT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 26,576,400
Market Cap $457M
Description
Arcturus Therapeutics Holdings Inc., an RNA medicines company, focuses on the development of vaccines for infectious, and liver and respiratory rare diseases in the United States. The company's development programs comprise LUNAR-OTC development program for ornithine transcarbamylase (OTC) deficiency; and LUNAR-CF program for cystic fibrosis lun...

More about ARCT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Zurcher Kantonalbank (Zurich Cantonalbank), based on Form 13F filings with the SEC.

News

Stay updated on Zurcher Kantonalbank (Zurich Cantonalbank) with notifications on news.

Account

Zurcher Kantonalbank (Zurich Cantonalbank) Arcturus Therapeutics Holdings Inc. Transaction History